Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/03/2013 | US8598200 KAT II inhibitors |
12/03/2013 | US8598199 Octahydropentalene compounds as chemokine receptor antagonists |
12/03/2013 | US8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy |
12/03/2013 | US8598195 Peptidomimetic compounds |
12/03/2013 | US8598194 Polycyclic agents for the treatment of respiratory syncytial virus infections |
12/03/2013 | US8598193 Polycyclic agents for the treatment of respiratory syncytial virus infections |
12/03/2013 | US8598192 Hydroxylamine substituted imidazoquinolines |
12/03/2013 | US8598190 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
12/03/2013 | US8598189 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
12/03/2013 | US8598188 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer |
12/03/2013 | US8598187 Arylamide pyrimidone compounds |
12/03/2013 | US8598185 Unitary pharmaceutical dosage form |
12/03/2013 | US8598184 Protein kinase inhibitors |
12/03/2013 | US8598181 Modulators of ATP-binding cassette transporters |
12/03/2013 | US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions |
12/03/2013 | US8598179 Pyrazole-carboxamide derivatives as P2Y12 antagonists |
12/03/2013 | US8598178 Controlled release sterile injectable aripiprazole formulation and method |
12/03/2013 | US8598177 Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments |
12/03/2013 | US8598176 Pyridazine compound and use thereof |
12/03/2013 | US8598175 Heteroarylamide pyrimidone derivatives |
12/03/2013 | US8598174 Pyridazinones, method of making, and method of use thereof |
12/03/2013 | US8598173 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors |
12/03/2013 | US8598172 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
12/03/2013 | US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders |
12/03/2013 | US8598170 Dual-acting oxazole antihypertensive agents |
12/03/2013 | US8598169 Biaryl compositions and methods for modulating a kinase cascade |
12/03/2013 | US8598168 Inhibitors of histone deacetylase |
12/03/2013 | US8598167 Substituted 6,5-fused bicyclic heteroaryl compounds |
12/03/2013 | US8598166 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof |
12/03/2013 | US8598164 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
12/03/2013 | US8598163 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders |
12/03/2013 | US8598162 Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders |
12/03/2013 | US8598160 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
12/03/2013 | US8598159 Therapeutic pyrazoloquinoline derivatives |
12/03/2013 | US8598158 Fused tricyclic compounds for the treatment of inflammatory disorders |
12/03/2013 | US8598156 Chemical compounds |
12/03/2013 | US8598155 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders |
12/03/2013 | US8598154 Pyridyl-amine fused azadecalin modulators |
12/03/2013 | US8598153 Method of treatment using fatty acid synthesis inhibitors |
12/03/2013 | US8598152 Co-crystals of tramadol and coxibs |
12/03/2013 | US8598151 Solid solution inducing layer for weak epitaxy growth of non-planar phthalocyanine |
12/03/2013 | US8598150 Composition and method for affecting obesity and related conditions |
12/03/2013 | US8598149 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists |
12/03/2013 | US8598148 Synthesis of tetracyclines and analogues thereof |
12/03/2013 | US8598146 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith |
12/03/2013 | US8598145 Mitochondrially delivered anti-cancer compounds |
12/03/2013 | US8598144 Method of administering hyaluronan formulation for the amelioration of osteoarthritis |
12/03/2013 | US8598142 Sulfated depolymerized derivatives of expolysaccharides (EPS) from mesophilic marine bacteria, method for preparing the same, and uses thereof in tissue regeneration |
12/03/2013 | US8598141 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
12/03/2013 | US8598138 Amphiphilic nucleotide cochleate compositions and methods of using the same |
12/03/2013 | US8598132 Glycosylated indolocarbazoles, method for obtaining same and uses thereof |
12/03/2013 | US8598131 Method for treatment of lung infections by administration of aminoglycosides by aerolisation |
12/03/2013 | US8598130 Insecticidal combinations |
12/03/2013 | US8598129 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
12/03/2013 | US8598128 Fructosylated puerarin, and preparation method and use thereof |
12/03/2013 | US8598119 Methods and compositions for sleep disorders and other disorders |
12/03/2013 | US8598116 Treatment of influenza virus infection |
12/03/2013 | US8598086 3-halo-(arly)-4-iminotetrahydropicolinates and their use as herbicides |
12/03/2013 | US8598078 Condensed anthran I lami de derivatives as insecticides |
12/03/2013 | US8597904 Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition |
12/03/2013 | US8597902 Peptide protection against ultraviolet light toxicity |
12/03/2013 | US8597876 Method of treating HIV infection |
12/03/2013 | US8597701 Transcription modulator compositions |
12/03/2013 | US8597698 Formulations for treatment of skin disorders |
12/03/2013 | US8597683 Modified release tranexamic acid formulation |
12/03/2013 | US8597681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
12/03/2013 | US8597672 Owl effigy |
12/03/2013 | US8597666 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
12/03/2013 | US8597665 Chimeric immunomodulatory compounds and methods of using the same-IV |
12/03/2013 | US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod |
12/03/2013 | US8597645 Cancer treatment with endothelin receptor antagonists |
12/03/2013 | US8597642 Tablettable formulations of lipophilic health ingredients |
12/03/2013 | US8597633 Subcutaneous delivery of poly(oxazoline) conjugates |
12/03/2013 | US8597632 Anionic oligosaccharide conjugates |
12/03/2013 | US8597631 Linear self-eliminating oligomers |
12/03/2013 | US8597616 Dry powder drug delivery formulations, methods of use, and devices therefore |
12/03/2013 | CA2723470C Nasal administration of benzodiazepines |
12/03/2013 | CA2694235C Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
12/03/2013 | CA2691917C Crystalline pyridazine compound |
12/03/2013 | CA2677185C Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
12/03/2013 | CA2658327C Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
12/03/2013 | CA2651039C Hyaluronic acid binary mixtures and therapeutic use thereof |
12/03/2013 | CA2637408C Foam-forming composition |
12/03/2013 | CA2626567C Method of preventive on-demand hormonal contraception |
12/03/2013 | CA2621830C 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
12/03/2013 | CA2615049C Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
12/03/2013 | CA2613477C Thiol-sensitive positive inotropes |
12/03/2013 | CA2611529C Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
12/03/2013 | CA2611312C Organic compounds |
12/03/2013 | CA2603509C Crystal form of asenapine maleate |
12/03/2013 | CA2599411C Enzyme inhibitors |
12/03/2013 | CA2594202C Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent |
12/03/2013 | CA2583499C Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
12/03/2013 | CA2572057C A photoactive biocompatible coating composition |
12/03/2013 | CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
12/03/2013 | CA2570780C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
12/03/2013 | CA2567801C Diarylalkanes as potent inhibitors of binuclear enzymes |
12/03/2013 | CA2539446C 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
12/03/2013 | CA2532859C Use of rotigotine for the treatment of depression |
12/03/2013 | CA2530302C Novel aminobenzophenone compounds |